In partnership with
Thank you for being a Global Market News subscriber.
Today’s Top Stories:
📉
U.S. Jobs Report: Payrolls Surge Past Forecasts, But Hidden Weakness Raises Red Flags
The U.S. labor market delivered a stronger-than-expected rebound in March, offering a temporary boost to confidence at a time when investors are increasingly questioning the strength of the economy.
💡Sponsor Spotlight
Wondering when you can retire?
To get it right, you need a plan that goes beyond just a target savings number. It requires a clear understanding of your goals, a realistic assessment of your time horizon, and a projection of your income and expenses. Without these elements, you may face uncertainty when you should be feeling confident.
Fisher Investments' guide, When to Retire: A Quick and Easy Planning Guide, helps you navigate these critical planning stages.
🤬
Trump Threatens to Destroy Iran’s Infrastructure. Oil Markets Brace for Shock
In a late-night post on Truth Social, Trump made it clear that the U.S. could intensify its military response against Iran in a way that goes far beyond previous strikes.
Why Pro Athletes Put Seven Figures Into This Medical Breakthrough
As a third-generation Brazilian Jiu-Jitsu master and former WWE champion, few people understand joint health like Rener and Eve Gracie.
They’ve dedicated their lives to keeping the body in peak shape. So when they made a seven-figure investment into Cytonics, the medical and investment world noticed.
Cytonics developed potentially the first and only treatment that can reverse the effects of osteoarthritis, the world’s most common cause of joint pain. This therapy attacks the root cause of the disease, finally making a solution possible. Big Pharma has chased for years.
With the osteoarthritis treatment market worth $500B, and current treatments only masking pain, it’s easy to see why the Gracies got involved. Now, you can join them as an early-stage Cytonics investor.
500M+ people need this breakthrough. Maximize your stake in Cytonics by claiming time-sensitive bonus shares before they receive FDA certification.
This is a paid advertisement for Cytonics Regulation CF offering. Please read the offering circular at https://cytonics.com/
💰
Prediction Markets Face Existential Threat as DOJ, CFTC Sue 3 States
The battle over the future of sports prediction markets just escalated in a big way—and the outcome could reshape an emerging multi-billion-dollar industry.
2026's IPOs Are Showing Real Earnings
The IPO drought is ending. 2026 could unleash the biggest wave of public offerings in over a decade.
These aren’t speculative startups. They’re dominant, revenue-generating giants with global scale.
The 7 Hottest IPOs on Wall Street’s 2026 Watchlist reveals which names could command massive attention next.
Want to advertise in Global Market News?
If your company is interested in reaching an audience of engaged and informed investors.
Know what you own, and know why you own it.
-Peter Lynch
You are receiving this email because you opted in to receive updates from Global Market News. This newsletter may contain sponsored content or advertisements. Information provided is for informational purposes only and should not be considered financial or investment advice. Always consult a financial advisor before making investment decisions.